Pharma IQ Glossary: Center For Biologics Evaluation and Research (CBER)
The Center For Biologics Evaluation and Research (CBER) is the Center within FDA that regulates biological products for human use under applicable federal laws, including the Public Health Service Act and the Federal Food, Drug and Cosmetic Act. CBER protects and advances the public health by ensuring that biological products are safe and effective and available to those who need them. CBER also provides the public with information to promote the safe and appropriate use of biological products.
Improving the Security, Quality & Compliance of your Biologic Operation
February 21 by Pharma IQIn the coming years, biologics are expected to make up a greater proportion of revenue growth for pharmaceutical companies, with some figures placing it as high as 60 per cent. The US Food...
Career Spotlight: Clinical Research Coordinator
August 30 by Pharma IQWorking as a clinical research coordinator or a clinical research associate can prove both a challenging and rewarding career.
Navigating the U.S. Department of Transportation’s Regulations for Biologics and Biological Agents
April 20 by Pharma IQPharma IQ chats with Eileen Edmonson, Pipeline and Hazardous Materials Safety Administration, U.S. Department of Transportation, about navigating the U.S. Department of Transportation’s regulations fo...
